Libertas is pleased to announce that Dr Prithviraj Bose has been recruited as the new Editor in Chief for Drug Target Insights.
Dr Bose is an Assistant Professor of Medicine at Virginia Commonwealth University, where he researches acute leukemias and other myeloid neoplasms and designs early phase clinical trials involving novel combinations of targeted agents.
Previous experience in haematology, oncology and pharmaceuticals at the University of Oklahoma make Dr Bose an excellent candidate for the Editor in Chief position of Drug Target Insights
Dr Bose brings some impressive credentials to Drug Target Insights Editorial Board, including having written several important clinical articles and book chapters
His past experiences make Dr Bose perfectly suited for the Editor in Chief role, and he will be able to deliver timely editorial decisions for us which will directly benefit authors and readers as papers in Drug Target Insights will be published quicker.
Drug Target Insights has been growing in popularity recently and the appointment of Dr Bose to the Editor in Chief role will help us to deal with the increased number of submissions.
Posts
